Methods of treatment using human anti-IL-23 antibodies
US10954297B2 · kind B2 · utility
0Cited by
24References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 20, 2018 |
| Grant date | Mar 23, 2021 |
| Priority date | — |
| Expiry date | Aug 19, 2038 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A human anti-IL-23p19 antibody, including isolated nucleic acids that encode at least one anti-IL-23p19 antibody, vectors, host cells, and methods of making and using thereof have applications in diagnostic and/or therapeutic compositions, methods and devices.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.